Literature DB >> 20035027

Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.

Jennifer B Rose1, Zlatina Naydenova, Andrew Bang, Megumi Eguchi, Gary Sweeney, Doo-Sup Choi, James R Hammond, Imogen R Coe.   

Abstract

To better understand the role of equilibrative nucleoside transporters (ENT) in purine nucleoside-dependent physiology of the cardiovascular system, we investigated whether the ENT1-null mouse heart was cardioprotected in response to ischemia (coronary occlusion for 30 min followed by reperfusion for 2 h). We observed that ENT1-null mouse hearts showed significantly less myocardial infarction compared with wild-type littermates. We confirmed that isolated wild-type adult mouse cardiomyocytes express predominantly ENT1, which is primarily responsible for purine nucleoside uptake in these cells. However, ENT1-null cardiomyocytes exhibit severely impaired nucleoside transport and lack ENT1 transcript and protein expression. Adenosine receptor expression profiles and expression levels of ENT2, ENT3, and ENT4 were similar in cardiomyocytes isolated from ENT1-null adult mice compared with cardiomyocytes isolated from wild-type littermates. Moreover, small interfering RNA knockdown of ENT1 in the cardiomyocyte cell line, HL-1, mimics findings in ENT1-null cardiomyocytes. Taken together, our data demonstrate that ENT1 plays an essential role in cardioprotection, most likely due to its effects in modulating purine nucleoside-dependent signaling and that the ENT1-null mouse is a powerful model system for the study of the role of ENTs in the physiology of the cardiomyocyte.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035027      PMCID: PMC3774072          DOI: 10.1152/ajpheart.00711.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  49 in total

1.  Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells: involvement of P2 receptors and adenosine transporters.

Authors:  Cleide Gonçalves da Silva; Robert Jarzyna; Anke Specht; Elzbieta Kaczmarek
Journal:  Circ Res       Date:  2006-02-23       Impact factor: 17.367

2.  Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.

Authors:  Pieter-Jan D F Guns; Tim Van Assche; Paul Fransen; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.

Authors:  Kay Barnes; Halina Dobrzynski; Sophie Foppolo; Paul R Beal; Fouzia Ismat; Elspeth R Scullion; Lijie Sun; James Tellez; Mabel W L Ritzel; William C Claycomb; Carol E Cass; James D Young; Rudi Billeter-Clark; Mark R Boyett; Stephen A Baldwin
Journal:  Circ Res       Date:  2006-07-27       Impact factor: 17.367

4.  Characterization of adenosine transport in H9c2 cardiomyoblasts.

Authors:  George P H Leung; Chung-Ming Tse; Ricky Y K Man
Journal:  Int J Cardiol       Date:  2006-07-05       Impact factor: 4.164

5.  Extracellular adenosine activates AMP-dependent protein kinase (AMPK).

Authors:  Ivette Aymerich; Fabienne Foufelle; Pascal Ferré; F Javier Casado; Marçal Pastor-Anglada
Journal:  J Cell Sci       Date:  2006-03-28       Impact factor: 5.285

6.  Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice.

Authors:  Tobias Eckle; Almut Grenz; David Köhler; Andreas Redel; Melanie Falk; Bernd Rolauffs; Hartmut Osswald; Franz Kehl; Holger K Eltzschig
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-09       Impact factor: 4.733

7.  Biomembrane affinity chromatographic analysis of nitrobenzylthioinosine binding to the reconstituted human red cell nucleoside transporter.

Authors:  L Haneskog; A Lundqvist; P Lundahl
Journal:  J Mol Recognit       Date:  1998       Impact factor: 2.137

8.  Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes.

Authors:  R Ray Morrison; Bunyen Teng; Peter J Oldenburg; Laxmansa C Katwa; Jurgen B Schnermann; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-05       Impact factor: 4.733

9.  Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice.

Authors:  Hong Lu; Chuan Chen; Curtis Klaassen
Journal:  Drug Metab Dispos       Date:  2004-09-15       Impact factor: 3.922

10.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

View more
  28 in total

Review 1.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

Review 2.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

Review 3.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

4.  Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.

Authors:  Almut Grenz; Jessica D Bauerle; Julee H Dalton; Douglas Ridyard; Alexander Badulak; Eunyoung Tak; Eóin N McNamee; Eric Clambey; Radu Moldovan; German Reyes; Jost Klawitter; Kelly Ambler; Kristann Magee; Uwe Christians; Kelley S Brodsky; Katya Ravid; Doo-Sup Choi; Jiaming Wen; Dmitriy Lukashev; Michael R Blackburn; Hartmut Osswald; Imogen R Coe; Bernd Nürnberg; Volker H Haase; Yang Xia; Michail Sitkovsky; Holger K Eltzschig
Journal:  J Clin Invest       Date:  2012-01-24       Impact factor: 14.808

Review 5.  The Hypoxia-Adenosine Link during Intestinal Inflammation.

Authors:  Jessica L Bowser; Luan H Phan; Holger K Eltzschig
Journal:  J Immunol       Date:  2018-02-01       Impact factor: 5.422

Review 6.  The hypoxia-adenosine link during inflammation.

Authors:  Jessica L Bowser; Jae W Lee; Xiaoyi Yuan; Holger K Eltzschig
Journal:  J Appl Physiol (1985)       Date:  2017-08-10

7.  Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial stunning in acutely ischemic hearts despite metabolic derangement: hot shot drug delivery before hypothermic cardioplegia.

Authors:  Anwar Saad Abd-Elfattah; Gert E Tuchy; Michael E Jessen; David R Salter; Jacques P Goldstein; Louis A Brunsting; Andrew S Wechsler
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-17       Impact factor: 5.209

Review 8.  Regulation of adenosine levels during cerebral ischemia.

Authors:  Stephanie Chu; Wei Xiong; Dali Zhang; Hanifi Soylu; Chao Sun; Benedict C Albensi; Fiona E Parkinson
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

Review 9.  Extracellular nucleotide and nucleoside signaling in vascular and blood disease.

Authors:  Marco Idzko; Davide Ferrari; Ann-Kathrin Riegel; Holger K Eltzschig
Journal:  Blood       Date:  2014-07-07       Impact factor: 22.113

10.  The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity.

Authors:  Azza Ramadan; Zlatina Naydenova; Katarina Stevanovic; Jennifer B Rose; Imogen R Coe
Journal:  Purinergic Signal       Date:  2013-10-27       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.